Hybridoma-based monoclonal antibody development. From immunisation to hybridoma screening and cloning.
Our monoclonal antibody development service provides high-quality, target-specific antibodies using established hybridoma technology.
Monoclonal antibodies recognize a single epitope, providing exceptional specificity.
Unlimited supply of identical antibodies from a single hybridoma clone.
Selection of IgG subtypes optimal for your application.
Contact our team to discuss your monoclonal antibody requirements.
Request a Quote